Oct 30, 2024
As Kaiser Permanente continues to evaluate how they cover medications for weight loss, Kaiser Permanente members in California will see changes in coverage of GLP-1 drugs and other Anti-Obesity Medications (AOMs) beginning January 1, 2025.
Effective with contract renewal on or after January 1, 2025, coverage for GLP-1 drugs and other AOMs will be removed from base coverage in California commercial plans when those drugs are prescribed solely for the purpose of weight loss for patients with BMI less than 40.
As a result of these changes, some members may lose coverage for GLP-1’s or other AOMs currently prescribed for weight loss purposes. Kaiser Permanente will begin outreach to impacted members by email beginning November 21, 2024. They will provide these members with details about the coverage change, including information about their comprehensive approach to weight management and resources available for members.
For more information and resources, visit Kaiser's website.
Contact your Amwins Connect Regional Sales Manager for more information.
